Cargando…

HLA-Bw4 in association with KIR3DL1 favors natural killer cell-mediated protection against severe COVID-19

Replicating SARS-CoV-2 has been shown to degrade HLA class I on target cells to evade the cytotoxic T-cell (CTL) response. HLA-I downregulation can be sensed by NK cells to unleash killer cell immunoglobulin-like receptor (KIR)-mediated self-inhibition by the cognate HLA-I ligands. Here, we investig...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Ruihua, Sun, Ying, Kuang, Bo-Hua, Yan, Xiao, Lei, Jinju, Lin, Yu-Xin, Tian, Jinxiu, Li, Yating, Xie, Xiaoduo, Chen, Tao, Zhang, Hui, Zeng, Yi-Xin, Zhao, Jincun, Feng, Lin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2023
Materias:	Coronaviruses
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10013568/ https://www.ncbi.nlm.nih.gov/pubmed/36849422 http://dx.doi.org/10.1080/22221751.2023.2185467

Ejemplares similares

KIR3DL1 and HLA-Bw4 Interaction Showed a Favorable Role in Patients with Myelodysplastic Syndromes in Chinese Southern Han
por: Zhen, Jian Xin, et al.
Publicado: (2020)

KIR3DL1-Negative CD8 T Cells and KIR3DL1-Negative Natural Killer Cells Contribute to the Advantageous Control of Early Human Immunodeficiency Virus Type 1 Infection in HLA-B Bw4 Homozygous Individuals
por: Zhang, Xin, et al.
Publicado: (2018)

The killer immunoglobulin-like receptor KIR3DL1 combination with HLA-Bw4 is protective against multiple sclerosis in African Americans
por: Hollenbach, Jill A., et al.
Publicado: (2016)

Follicular lymphoma patients with KIR2DL2 and KIR3DL1 and their ligands (HLA-C1 and HLA-Bw4) show improved outcome when receiving rituximab
por: Erbe, Amy K., et al.
Publicado: (2019)

In vitro education of human natural killer cells by KIR3DL1
por: Pugh, Jason, et al.
Publicado: (2019)

Conjunctival Scarring in Trachoma Is Associated with the HLA-C Ligand of KIR and Is Exacerbated by Heterozygosity at KIR2DL2/KIR2DL3
por: Roberts, Chrissy h., et al.
Publicado: (2014)

Influence of Interleukin IL-2 and IL-12 + IL-18 on Surface Expression of Immunoglobulin-Like Receptors KIR2DL1, KIR2DL2, and KIR3DL2 in Natural Killer Cells
por: Chrul, Slawomir, et al.
Publicado: (2006)

NK Cells Expressing the Inhibitory Killer Immunoglobulin-Like Receptors (iKIR) KIR2DL1, KIR2DL3 and KIR3DL1 Are Less Likely to Be CD16+ than Their iKIR Negative Counterparts
por: Isitman, Gamze, et al.
Publicado: (2016)

Structural plasticity of KIR2DL2 and KIR2DL3 enables altered docking geometries atop HLA-C
por: Moradi, Shoeib, et al.
Publicado: (2021)

Stable Frequencies of HLA-C(*)03:04/Peptide-Binding KIR2DL2/3(+) Natural Killer Cells Following Vaccination
por: Ziegler, Maja Christiane, et al.
Publicado: (2018)

Interaction between human leukocyte antigen (HLA-C) and killer cell Ig-like receptors (KIR2DL) inhibits the cytotoxicity of natural killer cells in patients with hepatoblastoma
por: Guo, Jing-Jie, et al.
Publicado: (2022)

ERAP1 Controls the Interaction of the Inhibitory Receptor KIR3DL1 With HLA-B51:01 by Affecting Natural Killer Cell Function
por: D’Amico, Silvia, et al.
Publicado: (2021)

Killer Immunoglobulin-Like Receptor 2DS2 (KIR2DS2), KIR2DL2-HLA-C1, and KIR2DL3 as Genetic Markers for Stratifying the Risk of Cytomegalovirus Infection in Kidney Transplant Recipients
por: Deborska-Materkowska, Dominika, et al.
Publicado: (2019)

Significant Association of KIR2DL3-HLA-C1 Combination with Cerebral Malaria and Implications for Co-evolution of KIR and HLA
por: Hirayasu, Kouyuki, et al.
Publicado: (2012)

Diverse functionality among human NK cell receptors for the C1 epitope of HLA-C: KIR2DS2, KIR2DL2, and KIR2DL3
por: Moesta, Achim K., et al.
Publicado: (2012)

Donor KIR3DL1/receptor HLA-Bw4-80I Combination Reduces Acute Leukemia Relapse after Umbilical Cord Blood Transplantation without in Vitro T-cell Depletion
por: Fang, Xinchen, et al.
Publicado: (2021)

KIR2DL2, KIR2DL5A and KIR2DL5B Genes Induce Susceptibility to Dengue Virus Infection, while KIR3DL3 and KIR2DS5 Confer Protection
por: Tapsoba, Aziz Sidi Aristide, et al.
Publicado: (2022)

NK3-specific natural killer cells are selectively inhibited by Bw4- positive HLA alleles with isoleucine 80
Publicado: (1994)

Activating KIR and HLA Bw4 Ligands Are Associated to Decreased Susceptibility to Pemphigus Foliaceus, an Autoimmune Blistering Skin Disease
por: Augusto, Danillo G., et al.
Publicado: (2012)

KIR3DL01 upregulation on gut natural killer cells in response to SIV infection of KIR- and MHC class I-defined rhesus macaques
por: Ries, Moritz, et al.
Publicado: (2017)

KIR and HLA haplotype analysis in a family lacking the KIR 2DL1-2DP1 genes
por: Vojvodić, S, et al.
Publicado: (2015)

Natural Killer Cells Generated From Human Induced Pluripotent Stem Cells Mature to CD56(bright)CD16(+)NKp80(+/-) In-Vitro and Express KIR2DL2/DL3 and KIR3DL1
por: Euchner, Johanna, et al.
Publicado: (2021)

KIR2DL4 (CD158d): An activation receptor for HLA-G
por: Rajagopalan, Sumati, et al.
Publicado: (2012)

Immunoinformatic Docking Approach for the Analysis of KIR3DL1/HLA-B Interaction
por: Grifoni, Alba, et al.
Publicado: (2013)

Roles of HLA-G/KIR2DL4 in Breast Cancer Immune Microenvironment
por: Zheng, Guoxu, et al.
Publicado: (2022)

HLA-Bw4-I-80 Isoform Differentially Influences Clinical Outcome As Compared to HLA-Bw4-T-80 and HLA-A-Bw4 Isoforms in Rituximab or Dinutuximab-Based Cancer Immunotherapy
por: Erbe, Amy K., et al.
Publicado: (2017)

Allele imputation for the killer cell immunoglobulin-like receptor KIR3DL1/S1
por: Harrison, Genelle F., et al.
Publicado: (2022)

Differential contribution of education through KIR2DL1, KIR2DL3, and KIR3DL1 to antibody‐dependent (AD) NK cell activation and ADCC
por: Lisovsky, Irene, et al.
Publicado: (2019)

The Bw4 public epitope of HLA-B molecules confers reactivity with natural killer cell clones that express NKB1, a putative HLA receptor
Publicado: (1995)

Influence of Glycosylation Inhibition on the Binding of KIR3DL1 to HLA-B*57:01
por: Salzberger, Wilhelm, et al.
Publicado: (2015)

The role of KIR2DL3/HLA-C*0802 in Brazilian patients with rheumatoid vasculitis
por: Nishimura, Wester Eidi, et al.
Publicado: (2015)

Diversity of Killer Cell Immunoglobulin-Like Receptor (KIR) Genotypes and KIR2DL2/3 Variants in HCV Treatment Outcome
por: Vidal-Castiñeira, Jose Ramón, et al.
Publicado: (2014)

The Interaction of HLA-C1/KIR2DL2/L3 Promoted KIR2DL2/L3 Single-Positive/NKG2C-Positive Natural Killer Cell Reconstitution, Raising the Incidence of aGVHD after Hematopoietic Stem Cell Transplantation
por: Zuo, Wei, et al.
Publicado: (2022)

Roles for HLA and KIR polymorphisms in natural killer cell repertoire selection and modulation of effector function
por: Yawata, Makoto, et al.
Publicado: (2006)

KIR2DL3 and KIR2DL1 show similar impact on licensing of human NK cells
por: Sim, Malcolm J. W., et al.
Publicado: (2015)

A novel antibody combination to identify KIR2DS2(high) natural killer cells in KIR2DL3/L2/S2 heterozygous donors
por: Blunt, Matthew D., et al.
Publicado: (2019)

The Roles of Uterine Natural Killer (NK) Cells and KIR/HLA-C Combination in the Development of Preeclampsia: A Systematic Review
por: Yang, Xiuhua, et al.
Publicado: (2020)

Presence of KIR2DL2/S2, KIR2DL5, and KIR3DL1 Molecules in Liver Transplant Recipients with Alcoholic Cirrhosis Could Be Implicated in Death by Graft Failure
por: Morales, Raquel, et al.
Publicado: (2023)

KIR2DS4 is a product of gene conversion with KIR3DL2 that introduced specificity for HLA-A(*)11 while diminishing avidity for HLA-C
por: Graef, Thorsten, et al.
Publicado: (2009)

Single Nucleotide Polymorphism in KIR2DL1 Is Associated With HLA-C Expression in Global Populations
por: Vargas, Luciana de Brito, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_svhns8vc9mmg2fijavhe4n1fm0